All ONS Member Community

Expand all | Collapse all

Oxaliplatin

  • 1.  Oxaliplatin

    Posted 22 days ago

    Is anyone still administering Oxaliplatin peripherally and if so how often is patient experiencing phlebitis issue which then requires a central line.  Our experience is nursing suggests all oxaliplatin patients should have a central line due to this very issue even if a CADD pump is not part of the treatment plan.  I am just curious of other experiences as we try to convince our providers.     

     

    Dawn L Demant | BAN, RN, OCN

    Core Charge RN, Infusion Center

    P: 320-229-5199 ext.70823 or 70753

    F: 320-229-5160

    CentraCare.com

     

    Coborn Cancer Center/Chemo infusion

    1900 Centracare Circle Ste. 1600

     

     

     

    Confidentiality Notice: This e-mail and any attachment may contain confidential information that is legally privileged. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless required to do so by law or regulation. If you are not the intended recipient, you are hereby notified any disclosure, copying, distribution or action taken in reliance on the contents of these documents is strictly prohibited. If you have received this transmission in error, please notify the sender immediately, reply to this transmission, or contact the CentraCare Information Systems Network Security staff by calling the IS Help Desk for assistance at 320-251-2700, ext. 54540, and delete these documents.


  • 2.  RE: Oxaliplatin

    Posted 21 days ago
    at our institiution, we require a mediport or PICC line for infusion of oxaliplatin because of the increase of phebititis and the pain it causes when infused peripherally.

    ------------------------------
    Claire Nekola RN BSN
    Director
    Northwell Health
    Massapequa NY
    ------------------------------



  • 3.  RE: Oxaliplatin

    Posted 15 days ago

    Thank you for your response Claire I appreciate it.

     

    Dawn L Demant | BAN, RN, OCN

    Core Charge RN, Infusion Center

    P: 320-229-5199 ext.70823 or 70753

    F: 320-229-5160

    CentraCare.com

     

    Coborn Cancer Center/Chemo infusion

    1900 Centracare Circle Ste. 1600

     

     

     

    Confidentiality Notice: This e-mail and any attachment may contain confidential information that is legally privileged. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless required to do so by law or regulation. If you are not the intended recipient, you are hereby notified any disclosure, copying, distribution or action taken in reliance on the contents of these documents is strictly prohibited. If you have received this transmission in error, please notify the sender immediately, reply to this transmission, or contact the CentraCare Information Systems Network Security staff by calling the IS Help Desk for assistance at 320-251-2700, ext. 54540, and delete these documents.





  • 4.  RE: Oxaliplatin

    Posted 21 days ago
    At our institution, we do have some patients that refuse a central line and have received oxaliplatin peripherally. Before doing so both the physician and nurse review the potential side effects and consequences of receiving the drug peripherally. There have been instances that I have seen that, due to poor or non-confident access after multiple treatment, that nurses have refused to treat a patient peripherally; this was then taken to the physician and nurse manager to decide how to proceed. In response to this, the practice has set forth a policy that outlines specific patient criteria that cannot receive oxaliplatin peripherally under any circumstances such as patient's diagnosed with diabetes or Raynaud's. It is our nursing staff preference that all patient's have central lines to receive this drug; however, from an ethics standpoint, we must also protect the patient's autonomy if they accept the risks involved.

    ------------------------------
    Tiffany Hopper RN BSN OCN
    BSN, RN, OCN
    Virginia Oncology Associates
    Virginia Beach VA
    ------------------------------



  • 5.  RE: Oxaliplatin

    Posted 15 days ago

    Thank you for your response Tiffany.  I appreciate it.

     

    Dawn L Demant | BAN, RN, OCN

    Core Charge RN, Infusion Center

    P: 320-229-5199 ext.70823 or 70753

    F: 320-229-5160

    CentraCare.com

     

    Coborn Cancer Center/Chemo infusion

    1900 Centracare Circle Ste. 1600

     

     

     

    Confidentiality Notice: This e-mail and any attachment may contain confidential information that is legally privileged. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless required to do so by law or regulation. If you are not the intended recipient, you are hereby notified any disclosure, copying, distribution or action taken in reliance on the contents of these documents is strictly prohibited. If you have received this transmission in error, please notify the sender immediately, reply to this transmission, or contact the CentraCare Information Systems Network Security staff by calling the IS Help Desk for assistance at 320-251-2700, ext. 54540, and delete these documents.